REDW Wealth’s Bristol-Myers Squibb BMY Stock Holding History

REDW Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,700	Closed	-$224K	–	84
2019 Q1	$224K	Buy	+4,700	New	+$234K	0.14%	75
2018 Q4	–	Sell	-6,200	Closed	-$385K	–	80
2018 Q3	$385K	Sell	6,200 -1,190	-16%	-$70.6K	0.26%	43
2018 Q2	$409K	Sell	7,390 -14	-0.2%	-$756	0.29%	41
2018 Q1	$468K	Sell	7,404 -342	-4%	-$22K	0.35%	33
2017 Q4	$475K	Buy	7,746 +3,008	+63%	+$188K	0.37%	36
2017 Q3	$302K	Buy	4,738 +8	+0.2%	+$467	0.25%	51
2017 Q2	$264K	Buy	4,730 +9	+0.2%	+$490	0.26%	58
2017 Q1	$257K	Sell	4,721 -214	-4%	-$11.7K	0.26%	59
2016 Q4	$288K	Buy	+4,935	New	+$270K	0.33%	48

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

REDW Wealth's BMY Position: Q2 2019 in Review

REDW Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 4,700 shares — an estimated $224K sold.

REDW Wealth first reported a position in BMY in Q4 2016 and held it in 9 quarters. The position peaked at $475K in Q4 2017. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

REDW Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
REDW Wealth sold 4,700 Bristol-Myers Squibb shares in Q2 2019, an estimated $224K.
REDW Wealth first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 9 quarters.
REDW Wealth's Bristol-Myers Squibb position peaked at $475K in Q4 2017.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on REDW Wealth's 13F filing for Q2 2019, filed 9 Aug 2019.